Niu S, Alkhuzam KA, Guan D, Jiao T, et al. 5-Year simulation of diabetes-related complications in people treated with tirzepatide or semaglutide versus insulin glargine. Diabetes Obes Metab 2023 Oct 22. doi: 10.1111/dom.15332.
PMID: 37867175